MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

69 hedge funds and large institutions have $184M invested in Marinus Pharmaceuticals, Inc in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-4
Holders Change %
-5.48%
% of All Funds
1.19%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
12
Increased
20
Reduced
16
Closed
16
Calls
$4.72M
Puts
$1.49M
Net Calls
+$3.24M
Net Calls Change
+$3.69M

Top Buyers

1
WP
1
Woodline Partners
California
$9.1M
2
AC
2
Antara Capital
New York
$6.63M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$3.51M
4
Walleye Capital
4
Walleye Capital
New York
$1.91M
5
Goldman Sachs
5
Goldman Sachs
New York
$818K

Top Sellers

1
6CM
1
683 Capital Management
New York
$6.48M
2
AG
2
Artal Group
Luxembourg
$1.04M
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
Millennium Management
4
Millennium Management
New York
$1.4M
5
Victory Capital Management
5
Victory Capital Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– -$68K -14,078 Closed
CG
77
Cutler Group
California
– -$64K -13,259 Closed
VRM
78
Vectors Research Management
New York
– -$10K -2,000 Closed
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
– -$1K -260 Closed
1 2 3
4